Maqsadli antifibrotik (Nintedanib) va endobronxial qopqoq terapiyasi

Click to Expand

KOAH va o'pka fibrozini boshqarish Fullscreen View

Clinical Summary

Klinik sharh va kasallik haqida maʼlumot

Ikki tomonlama bronxodilatatorlar, antifibrotik Nintedanib/Pirfenidon va o'pka hajmini kamaytirish uchun Zephyr endobronxial klapanlar.

Clinical Insight: Undergoing koah va o'pka fibrozini boshqarish at our accredited centers provides international patients with access to state-of-the-art navigation robotics, intraoperative neuromonitoring, and world-renowned surgical teams at a fraction of Western costs.

Clinical Manifestations

Belgilar va alomatlar

Dastlabki alomatlar

• • Early respiratory symptoms
• • Mild Progressive breathlessness, dry cough, low SpO2, honeycombing on HRCT

Umumiy alomatlar

• • Persistent Progressive breathlessness, dry cough, low SpO2, honeycombing on HRCT
• • Shortness of breath on exertion
• • Chronic cough or wheezing

Shoshilinch alomatlar

• • Acute respiratory failure SpO2 < 88%
• • Massive hemoptysis or severe pneumothorax

Etiology & Demographics

Sabablari va xavf omillari

Asosiy sabablar

• COPD & Idiopathic Pulmonary Fibrosis (IPF)
• Tobacco smoke & occupational dust exposure
• Airway hyperresponsiveness & parenchymal fibrosis

Kimlar yuqori xavf guruhida?

• Patients diagnosed with COPD & Idiopathic Pulmonary Fibrosis (IPF)
• Patients requiring expert pulmonology care

Pre-Operative Protocol

Tashxis va tekshiruvlar

Tashxis testi	Klinik maqsadi / Natijalar
HRCT Chest & Spirometry PFT Assessment for COPD & pulmonary fibrosis management	High-resolution anatomical imaging and pulmonary function evaluation

Surgical Techniques

Keng qamrovli davolash variantlari

Minimally Invasive: Interventional / VATS Surgery for COPD & pulmonary fibrosis management

Primary Choice

Board-certified pulmonologist or thoracic surgeon executed procedure.

Asosiy afzalliklari:

Minimally invasive keyhole or endoscopic approach

Preserves lung capacity

High clinical success

Multidisciplinary Pulmonary Care for COPD & pulmonary fibrosis management

Complex Cases

Comprehensive surgical or medical therapy protocol.

Tavsiya etiladi:

Advanced pulmonary pathology

Failed initial medical therapy

Hamkor shifoxonalardagi zamonaviy tibbiy texnologiyalar

Uniportal VATS Surgery EBUS-TBNA Staging Zephyr Endobronchial Valves

Clinical Risk Warning

Davolanmaslikning asoratlari

Transient air leak

Bronchoscopic irritation

Post-procedure cough

Post-Operative Milestone

Tiklanish grafigi, parhez va turmush tarzi

Tiklanish vaqti

Prosedura / Bosqich	Kutilayotgan tiklanish muddati
Post-Procedure Recovery	24 to 48 hours
Chest Drain Removal / Discharge	3 to 5 days
Full Active Living	2 to 3 weeks

Davolashdan keyingi parhez

• High protein balanced nutrition
• Hydration 2.5L/day

Turmush tarzini oʻzgartirish

• Perform incentive spirometry daily
• Strict complete smoking cessation

Zudlik bilan shifokorga murojaat qilish belgilari:

Sudden shortness of breath

Coughing up fresh blood

Fever > 100.4°F

Long-Term Health

Oldini olish va uzoq muddatli salomatlik

Complete smoking cessation and annual low-dose CT screening for smokers

Transparent Benchmark

Jahon boʻyicha narxlar solishtirmasi

Prosedura	USA (Avg)	India (ISG Network)	Turkey (Avg)	Thailand (Avg)
KOAH va o'pka fibrozini boshqarish	$35,000	$2,200	$8,500	$9,500

Patient Knowledgebase

Koʻp beriladigan savollar

What is the goal of treatment for COPD & pulmonary fibrosis management?

The main goal is restoring optimal pulmonary function and resolving breathlessness under board-certified pulmonologists.